\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ available\\.\ \(14\)\
\-\ medical\\ management\\ involves\\ pain\\ control\\,\\ transcutaneous\\ nerve\\ stimulation\\,\\ and\\ immobilization\\.\\ \\ in\\ advanced\\ disease\\ unaffected\\ by\\ activity\\ modification\\,\\ surgery\\ is\\ the\\ only\\ option\\.\\ core\\ decompression\\ with\\ or\\ without\\ bone\\ grafting\\ can\\ be\\ attempted\\ prior\\ to\\ any\\ bone\\ collapse\\.\\ \\ total\\ hip\\ arthroplasty\\ is\\ the\\ next\\ level\\ of\\ treatment\\ when\\ collapse\\ occurs\\,\\ femoral\\ head\\ deformities\\ develop\\,\\ or\\ secondary\\ osteoarthritis\\ develops\\.\ \(0\)\
\-\ ap\\ and\\ lateral\\ radiographs\\ of\\ the\\ hips\\ show\\ serpiginous\\ lines\\ of\\ sclerosis\\ along\\ the\\ femoral\\ heads\\.\\ \\ there\\ is\\ flattening\\ and\\ subchondral\\ fracture\\ of\\ the\\ right\\ lateral\\ femoral\\ head\\.\\ \\ additionally\\,\\ the\\ right\\ femoral\\ head\\ is\\ smaller\\ than\\ the\\ left\\.\ \(0\)\
\-\ mri\\ imaging\\ demonstrates\\ areas\\ of\\ decreased\\ signal\\ intensity\\ along\\ the\\ femoral\\ heads\\ bilaterally\\ on\\ t1\\ weighted\\ images\\.\\ \\ the\\ low\\ signal\\ intensity\\ on\\ t1\\ weight\\ images\\ is\\ consistent\\ with\\ edema\\.\\ \\ on\\ the\\ t2\\ weighted\\ images\\,\\ there\\ is\\ an\\ inner\\ line\\ of\\ increased\\ signal\\ intensity\\ with\\ an\\ outer\\ line\\ of\\ decreased\\ signal\\ intensity\\ in\\ both\\ hips\\.\\ \\ this\\ is\\ called\\ the\\ \\‚\\Ä\\údouble\\ rim\\‚\\Ä\\ù\\ sign\\ and\\ is\\ pathognomonic\\ for\\ avascular\\ necrosis\\.\\ \\ the\\ rim\\ identifies\\ the\\ interface\\ between\\ viable\\ and\\ dying\\ bone\\ marrow\\.\\ \\ the\\ high\\ signal\\ intensity\\ rim\\ is\\ indicative\\ of\\ granulation\\ tissue\\ and\\ the\\ adjacent\\ low\\ signal\\ intensity\\ rim\\ reflects\\ cellular\\ debris\\,\\ fibrous\\ tissue\\,\\ and\\ reactive\\ trabecular\\ bone\\.\\ \\ the\\ stir\\ images\\ show\\ linear\\ lines\\ of\\ increased\\ signal\\ intensity\\ along\\ the\\ femoral\\ heads\\ as\\ well\\ as\\ increased\\ signal\\ intensity\\ along\\ the\\ right\\ femoral\\ neck\\ consistent\\ with\\ bone\\ marrow\\ edema\\.\ \(0\)\
\-\ avascular\\ necrosis\\ of\\ the\\ femoral\\ heads\\.\ \(0\)\
\-\ compression\\ fracture\\ secondary\\ to\\ osteoporosis\ \(0\)\
\-\ inflammatory\\ synovitis\ \(1\)\
\-\ osteomyelitis\ \(170\)\
\-\ neoplastic\\ bone\\ lesion\ \(0\)\
\-\ transient\\ osteoporosis\ \(4\)\
\-\ causes\\ of\\ avascular\\ necrosis\\:\ \(0\)\
\-\ idiopathic\\,\\ corticosteriod\\ use\\,\\ alcohol\\ abuse\\,\\ sickle\\ cell\\ disease\\,\\ vasculitis\\,\\ trauma\\,\\ renal\\ transplant\\,\\ renal\\ osteodystrophy\\,\\ radiation\\ therapy\\,\\ pancreatitis\\,\\ gout\\,\\ gaucher\\ disease\\,\\ connective\\ tissue\\ diseases\\ \\(sle\\)\\,\\ caisson\\ disease\\,\\ metastatic\\ disease\\,\\ and\\ cytotoxic\\ agents\\.\ \(0\)\
\-\ the\\ patient\\ presented\\ with\\ a\\ 10\\ week\\ history\\ of\\ bilateral\\ hip\\ pain\\.\ \(0\)\
\-\ the\\ \\‚\\Ä\\údouble\\ rim\\‚\\Ä\\ù\\ sign\\ in\\ this\\ case\\ is\\ a\\ characteristic\\ finding\\ in\\ advanced\\ avascular\\ necrosis\\.\\ \\ using\\ ficat\\‚\\Ä\\ôs\\ classification\\,\\ this\\ patient\\ has\\ late\\ stage\\ 3\\/early\\ stage\\ 4\\ avascular\\ necrosis\\ of\\ the\\ femoral\\ head\\ on\\ the\\ right\\.\\ \\ the\\ flattening\\ of\\ the\\ femoral\\ head\\ is\\ seen\\ in\\ late\\ stage\\ 3\\ and\\ early\\ stage\\ 4\\ disease\\.\\ \\ he\\ has\\ stage\\ 2\\ avascular\\ necrosis\\ on\\ the\\ left\\.\\ \\ in\\ ficat\\‚\\Ä\\ôs\\ classification\\,\\ stage\\ 1\\ is\\ defined\\ as\\ a\\ normal\\ radiograph\\ with\\ clinical\\ symptoms\\.\\ \\ stage\\ 2\\ disease\\ is\\ mixed\\ osteopenia\\ and\\ sclerosis\\.\\ \\ stage\\ 3\\ is\\ subchondral\\ collapse\\ with\\ a\\ \\‚\\Ä\\úcrescent\\‚\\Ä\\ù\\ sign\\ seen\\ on\\ radiographs\\.\\ \\ stage\\ 4\\ is\\ articular\\ collapse\\,\\ and\\ stage\\ 5\\ disease\\ is\\ progression\\ to\\ degenerative\\ joint\\ disease\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ manaster\\ bj\\.\\ \\ adult\\ chronic\\ hip\\ pain\\:\\ radiographic\\ evaluation\\.\\ \\ radiographics\\ 2000\\;\\ 20\\:s3\\-s25\\.\ \(0\)\
\-\ 2\\.\\ \\ vande\\ berg\\ be\\,\\ et\\ al\\.\\ \\ mr\\ imaging\\ of\\ avascular\\ necrosis\\ and\\ transient\\ marrow\\ edema\\ of\\ the\\ femoral\\ head\\.\\ \\ radiographics\\ 1993\\;\\ 13\\:501\\-520\\.\ \(0\)\
\-\ 3\\.\\ \\ manaster\\ bj\\,\\ disler\\ dg\\,\\ may\\ da\\.\\ muskuloskeletal\\ imaging\\:\\ \\ the\\ requisites\\.\\ 2nd\\ ed\\.\\ philadelphia\\,\\ pa\\:\\ mosby\\,\\ inc\\.\\ 2002\\:\\ 167\\-173\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stage\\:\\ 0\\.06603323240812223\ \(0\)\
\-\ femoral\\:\\ 0\\.06478438076645263\ \(0\)\
\-\ avascular\\:\\ 0\\.05966034767853679\ \(0\)\
\-\ intensity\\:\\ 0\\.0447633431359319\ \(0\)\
\-\ necrosis\\:\\ 0\\.04277482788788575\ \(0\)\
\-\ heads\\:\\ 0\\.03752124829159502\ \(0\)\
\-\ rim\\:\\ 0\\.032762874933882906\ \(0\)\
\-\ signal\\:\\ 0\\.03265325116337361\ \(0\)\
\-\ collapse\\:\\ 0\\.03168744324258103\ \(0\)\
\-\ ficat\\:\\ 0\\.02942888131669041\ \(0\)\
\-\ head\\:\\ 0\\.026343492506238\ \(0\)\
\-\ manaster\\:\\ 0\\.02440607566045892\ \(0\)\
\-\ bone\\:\\ 0\\.023080811754998584\ \(0\)\
\-\ disease\\:\\ 0\\.022772894693734304\ \(0\)\
\-\ bj\\:\\ 0\\.022646989371394786\ \(0\)\
\-\ along\\:\\ 0\\.020464158527960262\ \(0\)\
\-\ marrow\\:\\ 0\\.0204308294490119\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.01876062414579751\ \(0\)\
\-\ hip\\:\\ 0\\.01849930637017097\ \(0\)\
\-\ hips\\:\\ 0\\.01822945213785593\ \(0\)\
\-\ radiographics\\:\\ 0\\.018148028747087604\ \(0\)\
\-\ classification\\:\\ 0\\.017694539098703523\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.01734511368358239\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.01724788778819774\ \(0\)\
\-\ lines\\:\\ 0\\.017045813622439083\ \(0\)\
\-\ flattening\\:\\ 0\\.01687186717611169\ \(0\)\
\-\ transient\\:\\ 0\\.016760375659203162\ \(0\)\
\-\ is\\:\\ 0\\.016298283431441324\ \(0\)\
\-\ subchondral\\:\\ 0\\.016249221317681764\ \(0\)\
\-\ late\\:\\ 0\\.016108951346012597\ \(0\)\
\-\ sign\\:\\ 0\\.016089383161761256\ \(0\)\
\-\ corticosteriod\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ 3\\/early\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ s3\\-s25\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ vande\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ 13\\:501\\-520\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ 167\\-173\\:\\ 0\\.015970142072403076\ \(0\)\
\-\ advanced\\:\\ 0\\.015843721621290514\ \(0\)\
\-\ \\,\\:\\ 0\\.01569333713143695\ \(0\)\
\-\ double\\:\\ 0\\.014976040568269124\ \(0\)\
\-\ transcutaneous\\:\\ 0\\.014714440658345205\ \(0\)\
\-\ berg\\:\\ 0\\.014714440658345205\ \(0\)\
\-\ \\:\\:\\ 0\\.014333195130316405\ \(0\)\
\-\ weighted\\:\\ 0\\.013462507232399636\ \(0\)\
\-\ identifies\\:\\ 0\\.013458739244287332\ \(0\)\
\-\ dying\\:\\ 0\\.013458739244287332\ \(0\)\
\-\ edema\\:\\ 0\\.013135453746909189\ \(0\)\
\-\ muskuloskeletal\\:\\ 0\\.013054493680312316\ \(0\)\
\-\ 4\\:\\ 0\\.012940064702060028\ \(0\)\
\-\ line\\:\\ 0\\.012725411289519647\ \(0\)\
\-\ reflects\\:\\ 0\\.012724201004960948\ \(0\)\
\-\ caisson\\:\\ 0\\.01220303783022946\ \(0\)\
\-\ disler\\:\\ 0\\.01220303783022946\ \(0\)\
\-\ images\\:\\ 0\\.011878723854705465\ \(0\)\
\-\ dg\\:\\ 0\\.011798792266254443\ \(0\)\
\-\ granulation\\:\\ 0\\.011468499590903075\ \(0\)\
\-\ increased\\:\\ 0\\.011361330335867694\ \(0\)\
\-\ crescent\\:\\ 0\\.011323494685697393\ \(0\)\
\-\ unaffected\\:\\ 0\\.011189241112955144\ \(0\)\
\-\ sclerosis\\:\\ 0\\.011120707367486757\ \(0\)\
\-\ modification\\:\\ 0\\.011064254026928058\ \(0\)\
\-\ tissue\\:\\ 0\\.011007723850285835\ \(0\)\
\-\ gaucher\\:\\ 0\\.010947336416171589\ \(0\)\
\-\ da\\:\\ 0\\.010947336416171589\ \(0\)\
\-\ imaging\\:\\ 0\\.0108808360024761\ \(0\)\
\-\ serpiginous\\:\\ 0\\.01083750920273602\ \(0\)\
\-\ viable\\:\\ 0\\.01083750920273602\ \(0\)\
\-\ 1993\\:\\ 0\\.010636013486956628\ \(0\)\
\-\ arthroplasty\\:\\ 0\\.01054309085219657\ \(0\)\
\-\ cytotoxic\\:\\ 0\\.01045470287362876\ \(0\)\
\-\ cellular\\:\\ 0\\.010370427482985837\ \(0\)\
\-\ grafting\\:\\ 0\\.010289898927603893\ \(0\)\
\-\ osteodystrophy\\:\\ 0\\.010212798176845204\ \(0\)\
\-\ inc\\:\\ 0\\.010212798176845204\ \(0\)\
\-\ stir\\:\\ 0\\.010067793271639522\ \(0\)\
\-\ trabecular\\:\\ 0\\.009999423112250307\ \(0\)\
\-\ requisites\\:\\ 0\\.009999423112250307\ \(0\)\
\-\ t1\\:\\ 0\\.009813389624000883\ \(0\)\
\-\ radiographs\\:\\ 0\\.009805329134790337\ \(0\)\
\-\ stimulation\\:\\ 0\\.009635889243659452\ \(0\)\
\-\ interface\\:\\ 0\\.009581807788678147\ \(0\)\
\-\ synovitis\\:\\ 0\\.009529294134922255\ \(0\)\
\-\ show\\:\\ 0\\.00950418816844792\ \(0\)\
\-\ debris\\:\\ 0\\.009428624114714264\ \(0\)\
\-\ develops\\:\\ 0\\.009380312072898755\ \(0\)\
\-\ renal\\:\\ 0\\.009302447642964019\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.009253720071179188\ \(0\)\
\-\ sle\\:\\ 0\\.009242656444315562\ \(0\)\
\-\ decreased\\:\\ 0\\.009205639140306376\ \(0\)\
\-\ connective\\:\\ 0\\.009114726068927966\ \(0\)\
\-\ mosby\\:\\ 0\\.009114726068927966\ \(0\)\
\-\ agents\\:\\ 0\\.009074014373543802\ \(0\)\
\-\ abuse\\:\\ 0\\.008995236996841377\ \(0\)\
\-\ osteopenia\\:\\ 0\\.008995236996841377\ \(0\)\
\-\ 2000\\:\\ 0\\.008957096762787333\ \(0\)\
\-\ s\\:\\ 0\\.008879592996791983\ \(0\)\
\-\ indicative\\:\\ 0\\.008847269549351762\ \(0\)\
\-\ deformities\\:\\ 0\\.008743721698192434\ \(0\)\
\-\ gout\\:\\ 0\\.0086778382848394\ \(0\)\
\-\ philadelphia\\:\\ 0\\.0086778382848394\ \(0\)\
\-\ secondary\\:\\ 0\\.00865590567575655\ \(0\)\
\-\ option\\:\\ 0\\.00864577383357237\ \(0\)\
\-\ attempted\\:\\ 0\\.00864577383357237\ \(0\)\
\-\ low\\:\\ 0\\.008609304539371013\ \(0\)\
\-\ core\\:\\ 0\\.0085832988769217\ \(0\)\
\-\ sickle\\:\\ 0\\.008552851198812316\ \(0\)\
\-\ transplant\\:\\ 0\\.008552851198812316\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.008493449345872114\ \(0\)\
\-\ 2002\\:\\ 0\\.008464463220244503\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.008380187829601581\ \(0\)\
\-\ immobilization\\:\\ 0\\.008326106374620274\ \(0\)\
\-\ inner\\:\\ 0\\.008326106374620274\ \(0\)\
\-\ articular\\:\\ 0\\.008299659274219636\ \(0\)\
\-\ outer\\:\\ 0\\.008222558523460948\ \(0\)\
\-\ decompression\\:\\ 0\\.008197570621047296\ \(0\)\
\-\ fracture\\:\\ 0\\.008163312790843402\ \(0\)\
\-\ called\\:\\ 0\\.008124610658840882\ \(0\)\
\-\ neoplastic\\:\\ 0\\.007921860810645257\ \(0\)\
\-\ vasculitis\\:\\ 0\\.007921860810645257\ \(0\)\
\-\ on\\:\\ 0\\.007868380569189435\ \(0\)\
\-\ next\\:\\ 0\\.007859024654870093\ \(0\)\
\-\ alcohol\\:\\ 0\\.0077982951403073346\ \(0\)\
\-\ diseases\\:\\ 0\\.0077982951403073346\ \(0\)\
\-\ adult\\:\\ 0\\.007758911106545728\ \(0\)\
\-\ develop\\:\\ 0\\.007720365094865865\ \(0\)\
\-\ 2nd\\:\\ 0\\.007720365094865865\ \(0\)\
\-\ progression\\:\\ 0\\.007701395348729461\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.007682622183809992\ \(0\)\
\-\ consistent\\:\\ 0\\.007591660394315953\ \(0\)\
\-\ smaller\\:\\ 0\\.007504872444754695\ \(0\)\
\-\ \\;\\:\\ 0\\.007338482566857224\ \(0\)\
\-\ reactive\\:\\ 0\\.007327597462863829\ \(0\)\
\-\ 3\\:\\ 0\\.007249911328646883\ \(0\)\
\-\ involves\\:\\ 0\\.007194440828818672\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.007194440828818672\ \(0\)\
\-\ control\\:\\ 0\\.007057133148801401\ \(0\)\
\-\ idiopathic\\:\\ 0\\.007057133148801401\ \(0\)\
\-\ as\\:\\ 0\\.007024877749424607\ \(0\)\
\-\ degenerative\\:\\ 0\\.007017891306806511\ \(0\)\
\-\ the\\:\\ 0\\.007012644876270875\ \(0\)\
\-\ mixed\\:\\ 0\\.0067987742589484266\ \(0\)\
\-\ using\\:\\ 0\\.006720240851568691\ \(0\)\
\-\ additionally\\:\\ 0\\.0067092946297281795\ \(0\)\
\-\ lateral\\:\\ 0\\.006690826252262864\ \(0\)\
\-\ 2\\:\\ 0\\.006667045277212124\ \(0\)\
\-\ total\\:\\ 0\\.006666159396587385\ \(0\)\
\-\ linear\\:\\ 0\\.006562611545428058\ \(0\)\
\-\ al\\:\\ 0\\.006562611545428058\ \(0\)\
\-\ characteristic\\:\\ 0\\.006552574986776581\ \(0\)\
\-\ ed\\:\\ 0\\.006542593726249462\ \(0\)\
\-\ right\\:\\ 0\\.006533563109495773\ \(0\)\
\-\ defined\\:\\ 0\\.006522794685430276\ \(0\)\
\-\ pa\\:\\ 0\\.006474223566860246\ \(0\)\
\-\ references\\:\\ 0\\.006436283034531907\ \(0\)\
\-\ occurs\\:\\ 0\\.006353715084357415\ \(0\)\
\-\ et\\:\\ 0\\.006335866721236018\ \(0\)\
\-\ fibrous\\:\\ 0\\.006257656264958465\ \(0\)\
\-\ use\\:\\ 0\\.006118549121455259\ \(0\)\
\-\ seen\\:\\ 0\\.006118215996622066\ \(0\)\
\-\ causes\\:\\ 0\\.00602641430762647\ \(0\)\
\-\ radiographic\\:\\ 0\\.005875660130052054\ \(0\)\
\-\ management\\:\\ 0\\.005841542470028336\ \(0\)\
\-\ has\\:\\ 0\\.0058141303278778185\ \(0\)\
\-\ activity\\:\\ 0\\.005808055486923077\ \(0\)\
\-\ compression\\:\\ 0\\.005794832112862186\ \(0\)\
\-\ pain\\:\\ 0\\.005671783519188776\ \(0\)\
\-\ ap\\:\\ 0\\.0056615198725406485\ \(0\)\
\-\ early\\:\\ 0\\.0056615198725406485\ \(0\)\
\-\ nerve\\:\\ 0\\.005577800953781352\ \(0\)\
\-\ 20\\:\\ 0\\.005566150790139521\ \(0\)\
\-\ weight\\:\\ 0\\.005548814828153742\ \(0\)\
\-\ inflammatory\\:\\ 0\\.005368325985855116\ \(0\)\
\-\ 3\\.\\:\\ 0\\.005296873572718709\ \(0\)\
\-\ week\\:\\ 0\\.005257274308565631\ \(0\)\
\-\ this\\:\\ 0\\.005223571811489853\ \(0\)\
\-\ 10\\:\\ 0\\.005218522152802374\ \(0\)\
\-\ areas\\:\\ 0\\.005208962266750121\ \(0\)\
\-\ available\\:\\ 0\\.005204201175434415\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0050846109393548975\ \(0\)\
\-\ radiation\\:\\ 0\\.005080165307178146\ \(0\)\
\-\ joint\\:\\ 0\\.005006212418554495\ \(0\)\
\-\ finding\\:\\ 0\\.00498924185695377\ \(0\)\
\-\ radiograph\\:\\ 0\\.004931066402031454\ \(0\)\
\-\ 2\\.\\:\\ 0\\.004922906053985975\ \(0\)\
\-\ mr\\:\\ 0\\.004918839623091366\ \(0\)\
\-\ between\\:\\ 0\\.004906694812000441\ \(0\)\
\-\ adjacent\\:\\ 0\\.004894630877054832\ \(0\)\
\-\ any\\:\\ 0\\.004874701146870097\ \(0\)\
\-\ 1\\.\\:\\ 0\\.004835487620104349\ \(0\)\
\-\ be\\:\\ 0\\.004774480881680903\ \(0\)\
\-\ medical\\:\\ 0\\.004763242391423921\ \(0\)\
\-\ clinical\\:\\ 0\\.004763242391423921\ \(0\)\
\-\ only\\:\\ 0\\.00465473126537126\ \(0\)\
\-\ there\\:\\ 0\\.004607665059655756\ \(0\)\
\-\ in\\:\\ 0\\.004580404675437554\ \(0\)\
\-\ neck\\:\\ 0\\.004545730320685656\ \(0\)\
\-\ 5\\:\\ 0\\.004529276127616238\ \(0\)\
\-\ evaluation\\:\\ 0\\.004496809412729725\ \(0\)\
\-\ level\\:\\ 0\\.004461755484867631\ \(0\)\
\-\ when\\:\\ 0\\.004433571082637692\ \(0\)\
\-\ t2\\:\\ 0\\.004381501392663681\ \(0\)\
\-\ chronic\\:\\ 0\\.004360488465411232\ \(0\)\
\-\ he\\:\\ 0\\.004319179967451122\ \(0\)\
\-\ an\\:\\ 0\\.004281394435814239\ \(0\)\
\-\ high\\:\\ 0\\.0042364964874579995\ \(0\)\
\-\ trauma\\:\\ 0\\.004233711561155668\ \(0\)\
\-\ presented\\:\\ 0\\.004219850788084074\ \(0\)\
\-\ cell\\:\\ 0\\.004181595491995446\ \(0\)\
\-\ therapy\\:\\ 0\\.004138842022175023\ \(0\)\
\-\ than\\:\\ 0\\.004056247925576583\ \(0\)\
\-\ prior\\:\\ 0\\.00397484197862747\ \(0\)\
\-\ both\\:\\ 0\\.0039532608526922485\ \(0\)\
\-\ and\\:\\ 0\\.003913239255048227\ \(0\)\
\-\ metastatic\\:\\ 0\\.0038969373253914677\ \(0\)\
\-\ symptoms\\:\\ 0\\.0038580751393082232\ \(0\)\
\-\ surgery\\:\\ 0\\.003759056276014991\ \(0\)\
\-\ bilateral\\:\\ 0\\.0037569161762942825\ \(0\)\
\-\ 1\\:\\ 0\\.0036835622607965706\ \(0\)\
\-\ without\\:\\ 0\\.0036449513883300005\ \(0\)\
\-\ or\\:\\ 0\\.0036287056121873463\ \(0\)\
\-\ mri\\:\\ 0\\.0035566591574540214\ \(0\)\
\-\ can\\:\\ 0\\.003511272377661358\ \(0\)\
\-\ well\\:\\ 0\\.003501958248131614\ \(0\)\
\-\ left\\:\\ 0\\.0034641495263511403\ \(0\)\
\-\ may\\:\\ 0\\.0033955224074241376\ \(0\)\
\-\ case\\:\\ 0\\.0033867833928754904\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0033815601479224387\ \(0\)\
\-\ of\\:\\ 0\\.0033769217622605344\ \(0\)\
\-\ lesion\\:\\ 0\\.0031531797572472006\ \(0\)\
\-\ treatment\\:\\ 0\\.0031333640572479837\ \(0\)\
\-\ patient\\:\\ 0\\.0031035939525956087\ \(0\)\
\-\ a\\:\\ 0\\.0028739116073811686\ \(0\)\
\-\ by\\:\\ 0\\.0025776646797914396\ \(0\)\
\-\ normal\\:\\ 0\\.0024268341568824295\ \(0\)\
\-\ \\.\\:\\ 0\\.002379497890582993\ \(0\)\
\-\ to\\:\\ 0\\.0023210223284944906\ \(0\)\
\-\ not\\:\\ 0\\.0022369903473585784\ \(0\)\
\-\ history\\:\\ 0\\.0021380698146867454\ \(0\)\
\-\ with\\:\\ 0\\.0014837486098355584\ \(0\)\
\-\ for\\:\\ 0\\.0013208480953672374\ \(0\)\
\-\ \\(\\:\\ 0\\.0013086263156591677\ \(0\)\
\-\ \\)\\:\\ 0\\.0012926407465820744\ \(0\)\
